全文获取类型
收费全文 | 22809篇 |
免费 | 1642篇 |
国内免费 | 89篇 |
专业分类
耳鼻咽喉 | 153篇 |
儿科学 | 774篇 |
妇产科学 | 523篇 |
基础医学 | 3316篇 |
口腔科学 | 329篇 |
临床医学 | 2782篇 |
内科学 | 5016篇 |
皮肤病学 | 481篇 |
神经病学 | 2398篇 |
特种医学 | 386篇 |
外科学 | 2028篇 |
综合类 | 131篇 |
一般理论 | 28篇 |
预防医学 | 2536篇 |
眼科学 | 246篇 |
药学 | 1532篇 |
中国医学 | 43篇 |
肿瘤学 | 1838篇 |
出版年
2024年 | 20篇 |
2023年 | 215篇 |
2022年 | 387篇 |
2021年 | 763篇 |
2020年 | 510篇 |
2019年 | 763篇 |
2018年 | 786篇 |
2017年 | 580篇 |
2016年 | 656篇 |
2015年 | 717篇 |
2014年 | 910篇 |
2013年 | 1191篇 |
2012年 | 1938篇 |
2011年 | 1949篇 |
2010年 | 1040篇 |
2009年 | 875篇 |
2008年 | 1517篇 |
2007年 | 1570篇 |
2006年 | 1545篇 |
2005年 | 1424篇 |
2004年 | 1316篇 |
2003年 | 1163篇 |
2002年 | 1020篇 |
2001年 | 142篇 |
2000年 | 90篇 |
1999年 | 151篇 |
1998年 | 192篇 |
1997年 | 138篇 |
1996年 | 133篇 |
1995年 | 121篇 |
1994年 | 82篇 |
1993年 | 86篇 |
1992年 | 44篇 |
1991年 | 43篇 |
1990年 | 42篇 |
1989年 | 48篇 |
1988年 | 34篇 |
1987年 | 23篇 |
1986年 | 31篇 |
1985年 | 27篇 |
1984年 | 39篇 |
1983年 | 26篇 |
1982年 | 24篇 |
1981年 | 25篇 |
1980年 | 19篇 |
1979年 | 13篇 |
1978年 | 15篇 |
1976年 | 16篇 |
1973年 | 12篇 |
1971年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Angela van Baardwijk Geert Bosmans Robert Jan van Suylen Marinus van Kroonenburgh Monique Hochstenbag Gijs Geskes Philippe Lambin Dirk De Ruysscher 《Radiotherapy and oncology》2008,87(1):55-58
We evaluated the feasibility to correlate intra-tumour heterogeneity as visualized on 18F-FDG PET with histology for NSCLC. For this purpose we used an ex-vivo model. The procedure was feasible in all operated patients. We have shown that this method is suitable for correlating intra-tumour heterogeneity in tracer uptake with histology. 相似文献
992.
993.
Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk. 总被引:1,自引:0,他引:1
994.
Angela B Mariotto Julia H Rowland Lynn A G Ries Steve Scoppa Eric J Feuer 《Cancer epidemiology, biomarkers & prevention》2007,16(3):566-571
OBJECTIVE: The present study was designed to estimate the number of and describe the pattern of disease among cancer survivors living with a history of multiple malignant tumors in the United States. METHODS: Incidence and follow-up data from the Surveillance, Epidemiology, and End Results program (1975-2001) were used to calculate the number of survivors with more than one malignant primary at January 1, 2002. U.S. prevalence counts were calculated by multiplying the age, sex, and race-specific prevalence proportions from the Surveillance, Epidemiology, and End Results program by the corresponding U.S. populations. RESULTS: We estimate that 756,467 people in the United States have been affected by cancer more than once between 1975 and 2001, representing almost 8% of the current cancer survivor population. Women whose first primary in that period was breast cancer represent 25% of survivors with multiple cancers, followed by men and women (15%) whose first primary was colorectal cancer and men (13%) whose first primary was prostate cancer. DISCUSSION: The findings in this report have important implications for public health practice. With individuals diagnosed with cancer living longer and the aging of the U.S. population, the number who will develop multiple malignancies is expected to increase. As a consequence, there is a growing need to promote effective cancer screening along with healthy life-styles among these at-risk populations if we are to ensure optimal physical and psychosocial well-being of these long-term cancer survivors and their families. Efforts to design and evaluate effective, efficient, and equitable approaches to surveillance for second malignancies will be critical in reducing the national burden of cancer. 相似文献
995.
Angela Wagner Howard Aizenstein Laura Mazurkewicz Julie Fudge Guido K Frank Karen Putnam Ursula F Bailer Lorie Fischer Walter H Kaye 《Neuropsychopharmacology》2008,33(3):513-523
Anorexia nervosa (AN) is an illness characterized by aversion to ingestion of normally palatable foods. We examined whether there is a primary disturbance of taste processing and experience of pleasure using a sucrose/water task in conjunction with functional magnetic resonance imaging (fMRI). To avoid confounding effects of illness, 16 women recovered from restricting-type AN were compared to 16 control women (CW). We used a region of interest-based fMRI approach to test the idea that individuals with AN have differential neural activation in primary and secondary taste cortical regions after sucrose and water administration. Compared to CW, individuals recovered from AN showed a significantly lower neural activation of the insula, including the primary cortical taste region, and ventral and dorsal striatum to both sucrose and water. In addition, insular neural activity correlated with pleasantness ratings for sucrose in CW, but not in AN subjects. Altered taste processing may occur in AN, based on differences in activity in insular-striatal circuits. These data provide the first evidence that individuals with AN process taste stimuli differently than controls, based on differences in neural activation patterns. 相似文献
996.
Angela Curtis Jackie Morton Chariklia Balafa Sheila MacNeil David J Gawkrodger Nicholas D Warren Gareth S Evans 《Toxicology in vitro》2007,21(5):809-819
This study was carried out to assess the effects of chromium and nickel upon isolated keratinocytes as an in vitro model of human skin. Keratinocytes were isolated from healthy volunteer skin samples of unknown metal sensitivity (n=10) and were compared with cells from patient biopsies of known metal sensitivity (n=7). Cells were dosed with a concentration range of nickel and chromium (0-10,000 microM) and cellular mitochondrial activity, viability, metal uptake and cytokine release were measured. Responses of primary versus passaged keratinocytes were also compared. Toxicity data from primary and passaged keratinocytes was statistically analysed by the non-linear Hill Plot model. Results showed that hexavalent chromium was significantly more cytotoxic, associated more with keratinocytes and induced a dose dependant release of IL-1alpha compared to nickel. Significant differences were observed between primary and passaged keratinocytes with regard to the toxicity of chromium and nickel and variation of response. No differences were observed in the cytotoxicity or cytokine release induced by chromium or nickel for the known sensitised biopsy patient samples (n=4) compared to patch test negative controls (n=3). The results from this study suggest human keratinocytes in vitro respond very differently to chromium and nickel. 相似文献
997.
Caroline Capitelli Adriana Sereniki Marcelo Meira Santos Lima Angela Braga Reksidler Sergio Tufik Maria Aparecida Barbato Fraz?o Vital 《European journal of pharmacology》2008,594(1-3):101-108
Parkinson's disease is a chronic neurological disease characterized by dopaminergic neuron degeneration in the substantia nigra pars compacta. Melatonin is a powerful antioxidant agent secreted by the pineal gland which has numerous physiological functions and seems to exert an important neuroprotective effect. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model has been used to understand the pathophysiology of the disease because of its capacity to mimic biochemical and histological features observed in Parkinson's disease. This study investigated the effect of pretreatment with melatonin (50 mg/kg) on MPTP-lesioned animals 24 h and 7 days after neurotoxin infusion using the open-field test, two-way avoidance task and immunohistochemistry. Twenty-four hours after lesioning, the MPTP+vehicle group exhibited hypolocomotion and significant loss of tyrosine hydroxylase-immunoreactive cells, whereas no differences in these parameters were observed in lesioned animals receiving melatonin. Seven days after surgery, the MPTP-lesioned rats did not show hypolocomotion compared to control animals, while there was a significant dopaminergic neuronal loss. In the two-way avoidance task, MPTP-treated animals presented a cognitive deficit compared to the control groups and melatonin administration did not repair this defect. The present results suggest that melatonin reduces neuronal loss in the MPTP animal model of Parkinson's disease. 相似文献
998.
999.
Amit Verma Sushovan Guha Parmeswaran Diagaradjane Ajaikumar B Kunnumakkara Angela M Sanguino Gabriel Lopez-Berestein Anil K Sood Bharat B Aggarwal Sunil Krishnan Juri G Gelovani Kapil Mehta 《Clinical cancer research》2008,14(8):2476-2483
PURPOSE: Tissue transglutaminase (TG2) is a multifunctional protein that is implicated in development of drug resistance and metastasis. Therefore, we examined therapeutic targeting of TG2 for inhibiting growth and metastasis of in vivo growing pancreatic ductal adenocarcinoma (PDAC) in nude mice. EXPERIMENTAL DESIGN: We implanted Panc-28 pancreatic cancer cells to induce orthotopic PDAC tumors in nude mice and determined the efficacy of liposomal TG2 small interfering RNA (siRNA) either alone or in combination with gemcitabine. RESULTS: We show that down-regulation of endogenous TG2 by siRNA could effectively block the growth of PDAC. Moreover, down-regulation of TG2 significantly enhanced the therapeutic efficacy of gemcitabine against PDAC and inhibited metastatic spread of the disease. The antitumor activity was related to inhibition of proliferation, angiogenesis, and Akt phosphorylation. CONCLUSION: siRNA-mediated down-regulation of TG2 represents a promising therapeutic approach for improved treatment of PDAC. 相似文献
1000.
Antonella Zannetti Francesca Iommelli Rosa Fonti Angela Papaccioli Jvana Sommella Anna Lettieri Giuseppe Pirozzi Roberto Bianco Giampaolo Tortora Marco Salvatore Silvana Del Vecchio 《Clinical cancer research》2008,14(16):5209-5219
PURPOSE: To test whether epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) induce detectable signals in tumor cells and whether such signals may reveal alterations of the apoptotic program. EXPERIMENTAL DESIGN: Tumor cells were treated with gefitinib or erlotinib and tested for their ability to accumulate 99mTc-Sestamibi, a radiolabeled lipophilic cation that localizes in mitochondria. Then we tested whether Bcl-2 and Bcl-xL alter the pattern of drug-dependent tracer accumulation while reducing tumor cell sensitivity to EGFR TKIs. The mechanism underlying the pattern of tracer accumulation was elucidated. Finally, imaging studies were done in animal models and lung cancer patients before and after treatment with EGFR TKIs using single-photon emission computed tomography and 99mTc-Sestamibi. RESULTS: Gefitinib increases accumulation of 99mTc-Sestamibi in Bcl-2-overexpressing cells and enhances the physical interaction of phosphorylated Bcl-2 with inositol trisphosphate receptor type 3 (IP3R3). Consequently, a relative increase of cytosolic and mitochondrial calcium levels occurs. Similarly, lung cancer cells showed an increase of tracer uptake and an enhanced interaction of Bcl-xL with IP3R3 on exposure to erlotinib concentrations achievable in plasma. The occurrence of these interactions was associated with an enhanced EGFR TKI-induced apoptosis resistance. Posttreatment imaging studies in nude mice bearing control and Bcl-2-overexpressing breast carcinomas showed a high tumor uptake of the tracer whereas baseline studies failed to visualize tumors. Similarly, an enhancement of tracer uptake could be detected in patients with lung cancer treated with erlotinib. CONCLUSION: EGFR TKIs generate detectable signals by Bcl-2/Bcl-xL modulation of IP3R3 in tumor cells. 相似文献